Leading the Life Sciences Century at the Convergence of Health, AI and Technology
Pitt BioForge Drives Advanced Manufacturing
The biomanufacturing hub at Hazelwood Green supported by a $100 million gift from the Richard King Mellon Foundation is propelling cutting-edge breakthroughs in the manufacturing of precision medicine tailored to disease prevention and treatment strategies based on the individual characteristics of each patient, including genes, environment and lifestyle. Under construction with a completion date of 2028, BioForge already has three projects underway and two in development.
Igniting the Health-AI Ecosystem
In March 2025, our offices of Innovation and Entrepreneurship and of the Senior Vice Chancellor for the Health Sciences collaborated to launch Pitt.INC, a program that is part of the University’s larger initiative to bring ideas and discoveries identified in the laboratory closer to becoming products and treatments for patients.
Transforming New Models of Health and Health Care Delivery
In partnership with Vizzhy Inc., Pitt is leveraging AI technology through the GAINMED platform to advance P5 medicine—predictive, preventative, personalized, precision and participatory care—and to better understand disease and health, while providing enhanced care to elevate the health of those in Pittsburgh and beyond.